Although , patients treated with ticagrelor were at lower risk for death where infection was either a direct cause or contributed to death ( 51 ( 0.5 % ) vs 76 ( 0.8 % ) , HR 0.67 ( 0.47 to 0.95 ) , p < 0.05 ) but not for bleeding ( 42 ( 0.5 % ) vs 42 ( 0.5 % ) , HR 0.99 ( 0.65 to 1.53 ) , p = 0.98 ) .